Skip to content

Advertisement

BMC Complementary and Alternative Medicine

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Phoyunnanin E inhibits migration of non-small cell lung cancer cells via suppression of epithelial-to-mesenchymal transition and integrin αv and integrin β3

  • Nareerat Petpiroon1, 2,
  • Boonchoo Sritularak3 and
  • Pithi Chanvorachote1, 2Email author
BMC Complementary and Alternative MedicineBMC series – open, inclusive and trusted201717:553

https://doi.org/10.1186/s12906-017-2059-7

Received: 10 August 2017

Accepted: 12 December 2017

Published: 29 December 2017

Back to article

Open Peer Review reports

Pre-publication versions of this article are available by contacting info@biomedcentral.com.

Original Submission
10 Aug 2017 Submitted Original manuscript
7 Sep 2017 Reviewed Reviewer Report - Mohamed Abdel-Daim
15 Sep 2017 Reviewed Reviewer Report - Saleemulla Khan
9 Oct 2017 Reviewed Reviewer Report - Yang Fan Yang
21 Oct 2017 Reviewed Reviewer Report - Raghavendra L Hallur
20 Nov 2017 Author responded Author comments - NAREERAT PETPIROON
Resubmission - Version 2
20 Nov 2017 Submitted Manuscript version 2
29 Nov 2017 Author responded Author comments - NAREERAT PETPIROON
Resubmission - Version 3
29 Nov 2017 Submitted Manuscript version 3
5 Dec 2017 Author responded Author comments - NAREERAT PETPIROON
Resubmission - Version 4
5 Dec 2017 Submitted Manuscript version 4
Publishing
12 Dec 2017 Editorially accepted
29 Dec 2017 Article published 10.1186/s12906-017-2059-7

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Cell-Based Drug and Health Product Development Research Unit, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, Thailand
(2)
Department of Pharmacology and Physiology, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, Thailand
(3)
Department of Pharmacognosy and Pharmaceutical Botany, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, Thailand

Advertisement